caffeine has been researched along with Astrocytosis in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment with caffeine to diabetic rats, resulted in improvement of structural changes and decrease in cytokine levels and immuno-markers, expression, and this was in a dose-dependent manner." | 5.91 | Caffeine protects against hippocampal alterations in type 2 diabetic rats via modulation of gliosis, inflammation and apoptosis. ( Al-Mahameed, AE; Fadel, R; Fatima, A; Jaradat, A; Nasr El-Din, WA; Othman, MA; Rashid, A; Tayem, Y, 2023) |
| "Pretreatment with caffeine to diabetic rats, resulted in improvement of structural changes and decrease in cytokine levels and immuno-markers, expression, and this was in a dose-dependent manner." | 1.91 | Caffeine protects against hippocampal alterations in type 2 diabetic rats via modulation of gliosis, inflammation and apoptosis. ( Al-Mahameed, AE; Fadel, R; Fatima, A; Jaradat, A; Nasr El-Din, WA; Othman, MA; Rashid, A; Tayem, Y, 2023) |
| "Caffeine, which is a competitive inhibitor of adenosine receptors, is commonly used as treatment for preterm apnoea in clinical settings." | 1.56 | Defining a Time Window for Neuroprotection and Glia Modulation by Caffeine After Neonatal Hypoxia-Ischaemia. ( Ådén, U; Blomgren, K; Bocchetta, E; Di Martino, E; Harris, RA; Mukai, T; Tsuji, S, 2020) |
| "Caffeine is widely used to treat apnea of prematurity, but the standard dosing regimen is not always sufficient to prevent apnea." | 1.40 | Impact of daily high-dose caffeine exposure on developing white matter of the immature ovine brain. ( Atik, A; Cheong, J; De Matteo, R; Harding, R; Rees, S; Tolcos, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Othman, MA | 1 |
| Fadel, R | 1 |
| Tayem, Y | 1 |
| Jaradat, A | 1 |
| Rashid, A | 1 |
| Fatima, A | 1 |
| Al-Mahameed, AE | 1 |
| Nasr El-Din, WA | 1 |
| Machado, DG | 1 |
| Lara, MVS | 1 |
| Dobler, PB | 1 |
| Almeida, RF | 1 |
| Porciúncula, LO | 1 |
| Di Martino, E | 1 |
| Bocchetta, E | 1 |
| Tsuji, S | 1 |
| Mukai, T | 1 |
| Harris, RA | 1 |
| Blomgren, K | 1 |
| Ådén, U | 1 |
| Atik, A | 1 |
| Cheong, J | 1 |
| Harding, R | 1 |
| Rees, S | 1 |
| De Matteo, R | 1 |
| Tolcos, M | 1 |
| Chen, X | 1 |
| Lan, X | 1 |
| Roche, I | 1 |
| Liu, R | 1 |
| Geiger, JD | 1 |
| Duarte, JM | 1 |
| Carvalho, RA | 1 |
| Cunha, RA | 1 |
| Gruetter, R | 1 |
6 other studies available for caffeine and Astrocytosis
| Article | Year |
|---|---|
Caffeine protects against hippocampal alterations in type 2 diabetic rats via modulation of gliosis, inflammation and apoptosis.
Topics: Animals; Apoptosis; Caffeine; Caspase 3; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellit | 2023 |
Caffeine prevents neurodegeneration and behavioral alterations in a mice model of agitated depression.
Topics: Animals; Behavior, Animal; Brain; Caffeine; Central Nervous System Stimulants; Depression; Gliosis; | 2020 |
Defining a Time Window for Neuroprotection and Glia Modulation by Caffeine After Neonatal Hypoxia-Ischaemia.
Topics: Animals; Brain Injuries; Caffeine; Demyelinating Diseases; DNA Fragmentation; Drug Administration Sc | 2020 |
Impact of daily high-dose caffeine exposure on developing white matter of the immature ovine brain.
Topics: Animals; Apoptosis; Axons; Brain; Caffeine; Female; Gliosis; Maternal Exposure; Myelin Basic Protein | 2014 |
Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Caffeine; Central Nervous System Stimulants; Cor | 2008 |
Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Caffeine; Central Nervous System Stimulants; Chronic Disease; Diabetes Melli | 2009 |